Stereotactic Body Radiotherapy for the Treatment of Renal Tumors()

The purpose of this study was to evaluate the response of actively growing renal masses to stereotactic body radiation therapy (SBRT). We retrospectively reviewed our institutional review board–approved kidney database and identified 4 patients who underwent SBRT, 15 Gy dose, for their rapidly growi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanzly, Michael, Creighton, Terrance, Mix, Michael, Zeeck, Kevin, Fung-Kee-Fung, Simon, Singh, Anurag K., Schwaab, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782072/
https://www.ncbi.nlm.nih.gov/pubmed/26958469
http://dx.doi.org/10.1016/j.eucr.2014.05.011
_version_ 1782419889457201152
author Hanzly, Michael
Creighton, Terrance
Mix, Michael
Zeeck, Kevin
Fung-Kee-Fung, Simon
Singh, Anurag K.
Schwaab, Thomas
author_facet Hanzly, Michael
Creighton, Terrance
Mix, Michael
Zeeck, Kevin
Fung-Kee-Fung, Simon
Singh, Anurag K.
Schwaab, Thomas
author_sort Hanzly, Michael
collection PubMed
description The purpose of this study was to evaluate the response of actively growing renal masses to stereotactic body radiation therapy (SBRT). We retrospectively reviewed our institutional review board–approved kidney database and identified 4 patients who underwent SBRT, 15 Gy dose, for their rapidly growing renal masses. Three patients had a decreased tumor size after radiation treatment by 20.8%, 38.1%, and 20%. The other patient had a size gain of 5.6%. This patient maintained a similar tumor growth rate before and after SBRT. Mean follow-up time was 13.8 months. SBRT represents an effective management option in select patients with larger rapidly growing kidney masses.
format Online
Article
Text
id pubmed-4782072
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-47820722016-03-08 Stereotactic Body Radiotherapy for the Treatment of Renal Tumors() Hanzly, Michael Creighton, Terrance Mix, Michael Zeeck, Kevin Fung-Kee-Fung, Simon Singh, Anurag K. Schwaab, Thomas Urol Case Rep Oncology The purpose of this study was to evaluate the response of actively growing renal masses to stereotactic body radiation therapy (SBRT). We retrospectively reviewed our institutional review board–approved kidney database and identified 4 patients who underwent SBRT, 15 Gy dose, for their rapidly growing renal masses. Three patients had a decreased tumor size after radiation treatment by 20.8%, 38.1%, and 20%. The other patient had a size gain of 5.6%. This patient maintained a similar tumor growth rate before and after SBRT. Mean follow-up time was 13.8 months. SBRT represents an effective management option in select patients with larger rapidly growing kidney masses. Elsevier 2014-06-28 /pmc/articles/PMC4782072/ /pubmed/26958469 http://dx.doi.org/10.1016/j.eucr.2014.05.011 Text en © 2014 The Authors http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Oncology
Hanzly, Michael
Creighton, Terrance
Mix, Michael
Zeeck, Kevin
Fung-Kee-Fung, Simon
Singh, Anurag K.
Schwaab, Thomas
Stereotactic Body Radiotherapy for the Treatment of Renal Tumors()
title Stereotactic Body Radiotherapy for the Treatment of Renal Tumors()
title_full Stereotactic Body Radiotherapy for the Treatment of Renal Tumors()
title_fullStr Stereotactic Body Radiotherapy for the Treatment of Renal Tumors()
title_full_unstemmed Stereotactic Body Radiotherapy for the Treatment of Renal Tumors()
title_short Stereotactic Body Radiotherapy for the Treatment of Renal Tumors()
title_sort stereotactic body radiotherapy for the treatment of renal tumors()
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782072/
https://www.ncbi.nlm.nih.gov/pubmed/26958469
http://dx.doi.org/10.1016/j.eucr.2014.05.011
work_keys_str_mv AT hanzlymichael stereotacticbodyradiotherapyforthetreatmentofrenaltumors
AT creightonterrance stereotacticbodyradiotherapyforthetreatmentofrenaltumors
AT mixmichael stereotacticbodyradiotherapyforthetreatmentofrenaltumors
AT zeeckkevin stereotacticbodyradiotherapyforthetreatmentofrenaltumors
AT fungkeefungsimon stereotacticbodyradiotherapyforthetreatmentofrenaltumors
AT singhanuragk stereotacticbodyradiotherapyforthetreatmentofrenaltumors
AT schwaabthomas stereotacticbodyradiotherapyforthetreatmentofrenaltumors

Ejemplares similares